Mechanism of Syngnathus extract in treating knee osteoarthritis of rats via regulating PI3K/Akt/mTOR signaling pathway.
10.19540/j.cnki.cjcmm.20241218.401
- Author:
Quan-Wei ZHENG
1
;
Guo-Wei WANG
1
;
Si-Xian WU
1
;
Tao ZHUO
1
;
Yi HE
1
;
Jian-Hang LIU
2
Author Information
1. Guangxi University of Chinese Medicine Nanning 530001, China.
2. Guangxi University of Chinese Medicine Nanning 530001, China Beihai Hospital of Chinese Medicine (Beihai Hospital Affiliated to Guangxi University of Chinese Medicine) Beihai 536000, China.
- Publication Type:Journal Article
- Keywords:
PI3K/Akt/mTOR signaling pathway;
Syngnathus extract;
autophagy;
knee osteoarthritis
- MeSH:
Animals;
TOR Serine-Threonine Kinases/genetics*;
Male;
Rats, Sprague-Dawley;
Signal Transduction/drug effects*;
Proto-Oncogene Proteins c-akt/genetics*;
Rats;
Osteoarthritis, Knee/metabolism*;
Drugs, Chinese Herbal/administration & dosage*;
Phosphatidylinositol 3-Kinases/genetics*;
Humans
- From:
China Journal of Chinese Materia Medica
2025;50(9):2442-2449
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the mechanism of action of Syngnathus extract in treating knee osteoarthritis of rats, forty-eight male SD rats were randomly divided into the blank group, model group, positive drug group, as well as low-dose, medium-dose, and high-dose groups of Syngnathus extract. The rat model of knee osteoarthritis was constructed by intra-articular injection of sodium iodoacetate. After successful modeling, celecoxib(18 mg·kg~(-1)·d~(-1)) and Syngnathus extract(0.4, 0.8, and 1.6 g·kg~(-1)·d~(-1)) were given in different groups by gavage intervention for two weeks. Hematoxylin-eosin(HE) staining was used to observe the histopathological changes of cartilage in knee joints, and enzyme-linked immunosorbent assay(ELISA) was used to detect the expression level of inflammatory factors in serum. Real-time fluorescence quantitative PCR, Western blot, and immunohistochemistry were used to detect the levels of phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target protein of rapamycin(mTOR) pathway-related mRNA and protein expression. The results showed that, comparied with the blank group, the cartilage surface of the knee joints of rats in the model group was uneven, with disorganized levels and defective cartilage tissue. The serum levels of interleukin-1β(IL-1β), interleukin-6(IL-6), and tumor necrosis factor-α(TNF-α) and the mRNA levels of PI3K, Akt, and mTOR in cartilage tissue, as well as the protein expression levels of phosphorylated PI3K(p-PI3K)/PI3K, phosphorylated Akt(p-Akt)/Akt, phosphorylated mTOR(p-mTOR)/mTOR, and P62 were significantly increased. Beclin1 protein expression was decreased. Comparied with the model group, the number of chondrocytes in the knee joint of rats in each group of Syngnathus extract increased, and the arrangement of chondrocytes was relatively neat. The cartilage layer was restored, and the serum levels of IL-1β, IL-6, and TNF-α, as well as the mRNA expression levels of PI3K, Akt, and mTOR in cartilage tissue were significantly reduced. The protein expression levels of p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and P62 were significantly reduced in the rats in the middle-dose and high-dose groups of Syngnathus extract, and the Beclin1 protein expression was significantly increased. The protein expression levels of p-PI3K/PI3K, p-Akt/Akt, and P62 in rats in the low-dose group of Syngnathus extract were significantly reduced. In summary, Syngnathus extract may be used to treat knee osteoarthritis by inhibiting the expression of PI3K/Akt/mTOR signaling pathway, so as to alleviate the inflammatory response in the organism, enhance the autophagy activity of chondrocytes, and reduce the apoptosis of chondrocytes.
